Abstract
We tested the hypothesis that HO-1 (heme oxygenase-1) activity varied between vascular smooth muscle cells (VSMC) in spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. HO-1 levels were measured under baseline and hemin-stimulated conditions and cell proliferation was monitored. Basal HO-1 levels in untreated cells were lower in SHR compared to WKY rats. Treatment with hemin increased HO-1 mRNA and protein levels in the cells obtained from WKY rats compared to that of SHR rats. However, hemin-treatment showed a greater inhibitory effect on VSMC proliferation in SHR rats than in WKY rats. Tin protoporphyrin IX (SnPPIX) showed a greater reversal of the anti-proliferative effect of hemin on cells from SHR rats than WKY. Similarly, VSMC proliferation from SHR was significantly inhibited in VSMC transfected with the HO-1 gene. These inhibitory effects were associated with cell cycle arrest in the G1 phase. The level of cyclin D, and cyclin dependent kinase inhibitor p21 was higher in SHR cells progressing through the G1 phase. Treatment of the cells with hemin down-regulated the expression of cyclin D and up-regulated that of p21. These results indicate that hemin, an HO-1 inducer, may play a more critical role in VSMC proliferation in SHR than WKY.
Similar content being viewed by others
References
Duckers, H. J., Boehm, M., True, A. L., Yet, S. F., San, H., Park, J. L., Clinton Webb, R., Lee, M. E., Nabel, G. J., and Nabel, E. G., Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med., 7, 693–698 (2001).
Dulic, V., Kaufmann W. K., Wilson S. J., Tlsty T. D., Lees E., Harper, J. W., Elledge, S. J., and Reed, S. I., p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013–1023 (1994).
Durante, W., Heme oxygenase-1 in growth control and its clinical application to vascular disease. J. Cell Physiol., 195, 373–382 (2003).
Gordon, D., Reidy, M. A., Benditt, E. P., and Schwartz S. M., Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U S A, 87, 4600–4604 (1990).
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805–816 (1993).
Hu, P. P., Shen, X., Huang, D., Liu, Y., Counter, C., and Wang, X. F., The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J. Biol. Chem., 274, 35381–35387 (1999).
Hunter, T., 1001 protein kinases redux—towards 2000. Semin. Cell Biol., 5, 367–376 (1994).
Integan, H. D. and Schiffrin, E. L., Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension, 38, 581–587 (2001).
Jacks, T. and Weinberg, R. A., Cell-cycle control and its watchman. Nature, 381, 643–644 (1996).
Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., and Chau, L. Y., Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 104, 1519–1525 (2001).
King, R. W., Jackson, P. K., and Kirschner, M. W., Mitosis in transition. Cell, 79, 563–571 (1994).
Lee, J. Y., Bielawska, A. E., and Obeid, L. M., Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp. Cell Res., 261, 303–311 (2000).
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T., p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9, 935–944 (1995).
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., and Pagano, M., Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol., 15, 2612–2624 (1995).
Okamoto, H., Fujioka, Y., Takahashi, A., Takahashi, T., Taniguchi, T., Ishikawa, Y., and Yokoyama, M., Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21 (WAF1). J. Atheroscler. Thromb., 13, 183–191 (2006).
Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G., Cyclin A is required at two points in the human cell cycle. EMBO J., 11, 961–971 (1992).
Resink, T. J., Scott-Burden, T., Baur, U., and Bühler, F. R., Increased proliferation fate and phosphoinositide turnover in cultured smooth muscle cells from spontaneously hypertensive rats. J. Hypertens. Suppl., 5, S145–S148 (1987).
Sherr, C. J., Cancer cell cycles. Science, 274, 1672–1677 (1996).
Sherr, C. J., G1 phase progression: cycling on cue. Cell, 79, 551–555 (1994).
Stocker, R. and Perrella, M. A., Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation, 114, 2178–2189 (2006).
Tanner, F. C., Greutert, H., Barandier, C., Frischknecht, K., and Lüscher, T. F., Different cell cycle regulation of vascular smooth muscle in genetic hypertension. Hypertension, 42, 184–188 (2003).
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D., p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701–704 (1993).
Yang, Z. Y., Simari, R. D., Perkins, N. D., San, H., Gordon, D., Nabel, G. J., and Nabel, E. G., Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. U S A, 93, 7905–7910 (1996).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jeon, E.M., Choi, H.C., Lee, K.Y. et al. Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch. Pharm. Res. 32, 375–382 (2009). https://doi.org/10.1007/s12272-009-1310-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1310-2